PGEN
Precigen, Inc.
NASDAQ · USHealthcareBiotechnology
$5.07+2.42%
Price as of Jul 20, 2026
PGEN capital
Precigen, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 4.86x
- Net debt / equity
- 4.49x
- Debt / assets
- 0.71x
- Debt / EBITDA
- -0.50x
- Net debt / EBITDA
- -0.47x
Liquidity & coverage
- Current ratio
- 4.82x
- Quick ratio
- 4.12x
- Cash ratio
- 2.67x
- Interest coverage
- -13.86x
- EBITDA / interest
- -28.81x
- Working capital
- $80.6M
Cash & dividend
- FCF / debt
- -1.20x
- Cash flow / debt
- -1.17x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.